Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety.
Expert Rev Anticancer Ther. 2021 Jun;21(6):583-590. doi: 10.1080/14737140.2021.1882856. Epub 2021 Feb 14.
Expert Rev Anticancer Ther. 2021.
PMID: 33504219
Free PMC article.
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study.
Nebhan CA, Johnson DB, Sullivan RJ, Amaria RN, Flaherty KT, Sosman JA, Davies MA.
Nebhan CA, et al.
Oncologist. 2021 Sep;26(9):731-e1498. doi: 10.1002/onco.13795. Epub 2021 May 4.
Oncologist. 2021.
PMID: 33861486
Free PMC article.
Clinical Trial.
Item in Clipboard
MEK inhibitors in non-V600 BRAF mutations and fusions.
Johnson DB, Nebhan CA, Noel MS.
Johnson DB, et al.
Oncotarget. 2020 Nov 3;11(44):3900-3903. doi: 10.18632/oncotarget.27788. eCollection 2020 Nov 3.
Oncotarget. 2020.
PMID: 33216832
Free PMC article.
Item in Clipboard
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Yan C, Saleh N, Yang J, Nebhan CA, Vilgelm AE, Reddy EP, Roland JT, Johnson DB, Chen SC, Shattuck-Brandt RL, Ayers GD, Richmond A.
Yan C, et al.
Mol Cancer. 2021 Jun 6;20(1):85. doi: 10.1186/s12943-021-01366-y.
Mol Cancer. 2021.
PMID: 34092233
Free PMC article.
Item in Clipboard
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Fahey CC, Nebhan CA, York S, Davis NB, Hurley PJ, Gordetsky JB, Schaffer KR.
Fahey CC, et al.
Int J Mol Sci. 2023 Nov 9;24(22):16109. doi: 10.3390/ijms242216109.
Int J Mol Sci. 2023.
PMID: 38003302
Free PMC article.
Item in Clipboard
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Williams CB, Nebhan CA, Yang J, Starnes LS, Yan C, Vilgelm AE, Chen SC, Dan Ayers G, Abramson V, Mayer IA, Richmond A.
Williams CB, et al.
Breast Cancer Res Treat. 2020 Nov;184(2):357-364. doi: 10.1007/s10549-020-05846-5. Epub 2020 Aug 7.
Breast Cancer Res Treat. 2020.
PMID: 32767201
Free PMC article.
Item in Clipboard
Cite
Cite